Phoenix Cardiac

Cary, United States Founded: 2012 • Age: 14 yrs
Cardiac medical devices for heart valve repair are developed.

About Phoenix Cardiac

Phoenix Cardiac is a Healthcare company based in Cary (United States) founded in 2012 by Gopal Muppirala. Cardiac medical devices for heart valve repair are developed. Phoenix Cardiac has raised $7.18 million across 2 funding rounds. Its chief executive, as recorded, is Gopal Muppirala. Phoenix Cardiac offers products and services including Flower Delivery, Cake Delivery, Gift Delivery, and Chocolates Delivery. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity in India is Phoenix Cardiac Devices Private Limited (U33100TG2012PTC082781). Its competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology; 3 of its 3 listed competitors have raised funding.

Company details

Phoenix Cardiac was founded in 2012 and is based in Cary, United States. The company operates in the medical device sector, focusing on cardiac technologies. A device named BACE is developed for treating mitral valve regurgitation through the application of light pressure to ensure proper closure of valve leaflets. The implant is secured around the atrio-ventricular groove, encompassing the ventricular wall and mitral valve annulus.

  • Headquarters Cary, United States
  • Founders Gopal Muppirala
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website phoenixcardiac.com
  • Legal Name Phoenix Cardiac Devices Private Limited
  • Date of Incorporation 30 Aug, 2012
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Indian entity net loss
    -₹74,602

    FY 2023 · 0% margin

  • Indian entity EBITDA
    -₹40,000

    FY 2023 · 0% margin

  • Total Equity Funding
    $7.18M (USD)

    in 2 rounds

  • Latest Funding Round
    $4.97M (USD), Series A

    May 2019

Products & Services of Phoenix Cardiac

Phoenix Cardiac offers a comprehensive portfolio of products and services, including Flower Delivery, Cake Delivery, Gift Delivery, and Chocolates Delivery.

Flower Delivery
Online Service

Service for sending fresh flowers across India for occasions

Cake Delivery
Online Service

Delivery of fresh cakes for birthdays and events

Gift Delivery
Online Service

Platform for sending gifts like chocolates and hampers

Chocolates Delivery
Online Service

Service for delivering chocolates and sweets to recipients

Funding Insights of Phoenix Cardiac

Phoenix Cardiac has successfully raised a total of $7.18M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.97 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.18M
  • Total Rounds 2
  • Last Round Series A β€” $4.97M
  • First Round $2.21M

    (Aug 2018)

All 2 funding rounds of Phoenix Cardiac with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2019$4.97MSeries A––
–
Aug 2018$2.21MSeed––
–

Board of directors of Phoenix Cardiac Devices Private Limited (Phoenix Cardiac)

Phoenix Cardiac Devices Private Limited is the primary company behind Phoenix Cardiac. The board of Phoenix Cardiac Devices Private Limited currently have 3 directors; the longest-serving is Ramagopal Somasekhara Muppirala, appointed in 2012. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ramagopal Somasekhara Muppirala
DIN 01892071
Director30 Aug 201214 yrs 2 moPhoenix Cardiac Devices Private Limited
Sreekanth Reddy Beeram
DIN 00074477
Director30 Nov 20169 yrs 11 moPhoenix Cardiac Devices Private Limited
Vikas Saluguti
DIN 03145832
Director30 Nov 20169 yrs 11 moPhoenix Cardiac Devices Private Limited

People of Phoenix Cardiac

1 people are tracked at Phoenix Cardiac (1 in leadership).

NameRoleGroup
Gopal Muppirala
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Phoenix Cardiac

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Phoenix Cardiac

Figures of Phoenix Cardiac Devices Private Limited, the primary company behind Phoenix Cardiac, for FY 2023. Net loss was -₹74,602 (0% margin). EBITDA was -₹40,000 (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.

  • -₹74,602Net loss · 0% margin
  • -₹40,000EBITDA · 0% margin
  • ₹1.01 CrPaid-up capital
  • -100%Revenue CAGR, 3 years
  • -100%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Phoenix Cardiac Devices Private Limited are on its company page.

Premium access

Detailed financial statements for Phoenix Cardiac

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Phoenix Cardiac

3 dated milestones of Phoenix Cardiac across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Phoenix Cardiac is founded.
  2. Funding First funding round of $2.2M.
  3. Funding Latest funding round, Series A, of $5.0M.

Competitors of Phoenix Cardiac

Phoenix Cardiac has 3 listed competitors in our database, 3 of them funded. They include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
shockwavemedical.com2009Santa Clara, United States$147.5M1,394
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
cardiacdimensions.com2001Kirkland, United States$260.8M31
Invasive cardiac implants for heart failure treatment are developed.
jenavalve.com2006Irvine, United States$363.7M198
Pericardial transcatheter aortic valve replacement systems are provided.
Premium access

Detailed competitors of Phoenix Cardiac

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Phoenix Cardiac (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Phoenix Cardiac

Cary-based Phoenix Cardiac Raises $2.1M
Charlotteraleigh β€’ 8 years ago
Premium access

Complete news archive for Phoenix Cardiac

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Phoenix Cardiac

Phoenix Cardiac was founded in 2012 and raised its 1st funding round 6 years after it was founded.

Phoenix Cardiac is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.

Gopal Muppirala is the CEO of Phoenix Cardiac, as recorded in our data. They have also founded this company.

Phoenix Cardiac is a funded company, having raised a total of $7.18M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.21M, raised on Aug 2018.

Phoenix Cardiac was founded in 2012 and is based in Cary, United States. The company operates in the medical device sector, focusing on cardiac technologies. A device named BACE is developed for treating mitral valve regurgitation through the application of light pressure to ensure proper closure of valve leaflets. The implant is secured around the atrio-ventricular groove, encompassing the ventricular wall and mitral valve annulus.

Phoenix Cardiac's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.

Phoenix Cardiac offers Flower Delivery, Cake Delivery, Gift Delivery, and Chocolates Delivery.

Phoenix Cardiac operates through Phoenix Cardiac Devices Private Limited.

The legal entities of Phoenix Cardiac currently have 3 directors, including Sreekanth Reddy Beeram, Ramagopal Somasekhara Muppirala, Vikas Saluguti.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available